131 related articles for article (PubMed ID: 10479149)
1. Interaction of Shiga toxins with human brain microvascular endothelial cells: cytokines as sensitizing agents.
Ramegowda B; Samuel JE; Tesh VL
J Infect Dis; 1999 Oct; 180(4):1205-13. PubMed ID: 10479149
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor and interleukin 1 induce expression of the glycolipid verotoxin receptor in human endothelial cells. Implications for the pathogenesis of the haemolytic uraemic syndrome.
Van de Kar NC; Monnens LA; Van Hinsbergh VW
Behring Inst Mitt; 1993 Aug; (92):202-9. PubMed ID: 8250811
[TBL] [Abstract][Full Text] [Related]
3. Induction of apoptosis of human brain microvascular endothelial cells by shiga toxin 1.
Ergonul Z; Hughes AK; Kohan DE
J Infect Dis; 2003 Jan; 187(1):154-8. PubMed ID: 12508161
[TBL] [Abstract][Full Text] [Related]
4. Escherichia coli Shiga toxin 1 and TNF-alpha induce cytokine release by human cerebral microvascular endothelial cells.
Eisenhauer PB; Jacewicz MS; Conn KJ; Koul O; Wells JM; Fine RE; Newburg DS
Microb Pathog; 2004 Apr; 36(4):189-96. PubMed ID: 15001224
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis for up-regulation by inflammatory cytokines of Shiga toxin 1 cytotoxicity and globotriaosylceramide expression.
Stricklett PK; Hughes AK; Ergonul Z; Kohan DE
J Infect Dis; 2002 Oct; 186(7):976-82. PubMed ID: 12232838
[TBL] [Abstract][Full Text] [Related]
6. Human microvascular endothelial cells are strongly sensitive to Shiga toxins.
Ohmi K; Kiyokawa N; Takeda T; Fujimoto J
Biochem Biophys Res Commun; 1998 Oct; 251(1):137-41. PubMed ID: 9790920
[TBL] [Abstract][Full Text] [Related]
7. Shiga toxin-associated hemolytic uremic syndrome: interleukin-1 beta enhancement of Shiga toxin cytotoxicity toward human vascular endothelial cells in vitro.
Kaye SA; Louise CB; Boyd B; Lingwood CA; Obrig TG
Infect Immun; 1993 Sep; 61(9):3886-91. PubMed ID: 8359910
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the role of Shiga and Shiga-like toxins in mediating direct damage to human vascular endothelial cells.
Tesh VL; Samuel JE; Perera LP; Sharefkin JB; O'Brien AD
J Infect Dis; 1991 Aug; 164(2):344-52. PubMed ID: 1649877
[TBL] [Abstract][Full Text] [Related]
9. Shiga toxin type 1 activates tumor necrosis factor-alpha gene transcription and nuclear translocation of the transcriptional activators nuclear factor-kappaB and activator protein-1.
Sakiri R; Ramegowda B; Tesh VL
Blood; 1998 Jul; 92(2):558-66. PubMed ID: 9657756
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of Shiga-like toxin 1 on cytokine- and butyrate-treated human umbilical and saphenous vein endothelial cells.
Keusch GT; Acheson DW; Aaldering L; Erban J; Jacewicz MS
J Infect Dis; 1996 May; 173(5):1164-70. PubMed ID: 8627068
[TBL] [Abstract][Full Text] [Related]
11. The effect of shiga toxin and sonicates of Shigella isolates from children with neurologic manifestation on neuroblastoma cell lines.
Ashkenazi S; Yuhas Y; Even-Tov S; Kaminsky E; Danon YL
Isr J Med Sci; 1994 Aug; 30(8):604-10. PubMed ID: 8045741
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome.
van de Kar NC; Monnens LA; Karmali MA; van Hinsbergh VW
Blood; 1992 Dec; 80(11):2755-64. PubMed ID: 1333300
[TBL] [Abstract][Full Text] [Related]
13. Human intestinal epithelial and smooth muscle cells are potent producers of IL-6.
Ng EK; Panesar N; Longo WE; Shapiro MJ; Kaminski DL; Tolman KC; Mazuski JE
Mediators Inflamm; 2003 Feb; 12(1):3-8. PubMed ID: 12745542
[TBL] [Abstract][Full Text] [Related]
14. Shiga toxins, glycosphingolipid diversity, and endothelial cell injury.
Müthing J; Schweppe CH; Karch H; Friedrich AW
Thromb Haemost; 2009 Feb; 101(2):252-64. PubMed ID: 19190807
[TBL] [Abstract][Full Text] [Related]
15. Sensitization of human umbilical vein endothelial cells to Shiga toxin: involvement of protein kinase C and NF-kappaB.
Louise CB; Tran MC; Obrig TG
Infect Immun; 1997 Aug; 65(8):3337-44. PubMed ID: 9234795
[TBL] [Abstract][Full Text] [Related]
16. Uncommon membrane distribution of Shiga toxin glycosphingolipid receptors in toxin-sensitive human glomerular microvascular endothelial cells.
Betz J; Bauwens A; Kunsmann L; Bielaszewska M; Mormann M; Humpf HU; Karch H; Friedrich AW; Müthing J
Biol Chem; 2012 Mar; 393(3):133-47. PubMed ID: 22718629
[TBL] [Abstract][Full Text] [Related]
17. Comparative evaluation of apoptosis induced by Shiga toxin 1 and/or lipopolysaccharides in human monocytic and macrophage-like cells.
Harrison LM; Cherla RP; van den Hoogen C; van Haaften WC; Lee SY; Tesh VL
Microb Pathog; 2005; 38(2-3):63-76. PubMed ID: 15748808
[TBL] [Abstract][Full Text] [Related]
18. Aspects of interleukin-8 gene expression by gingival and dermal fibroblasts stimulated with interleukin-1beta or tumour necrosis factor alpha.
Myokai F; Koyama E; Nishikawa K; Noji S; Murayama Y; Taniguchi S
J Int Acad Periodontol; 2004 Jan; 6(1):21-8. PubMed ID: 14964491
[TBL] [Abstract][Full Text] [Related]
19. Endothelial heterogeneity in Shiga toxin receptors and responses.
Obrig TG; Louise CB; Lingwood CA; Boyd B; Barley-Maloney L; Daniel TO
J Biol Chem; 1993 Jul; 268(21):15484-8. PubMed ID: 8340376
[TBL] [Abstract][Full Text] [Related]
20. [Effect of cytokines on the expression of Shiga toxin toxicity].
Nakane A; Sasaki S
Nihon Rinsho; 2002 Jun; 60(6):1089-94. PubMed ID: 12078078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
